Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
Mannheim, Germany.
J Diabetes Sci Technol. 2024 Jul;18(4):857-865. doi: 10.1177/19322968221134639. Epub 2022 Nov 3.
The accuracy of continuous glucose monitoring (CGM) systems is crucial for the management of glucose levels in individuals with diabetes mellitus. However, the discussion of CGM accuracy is challenged by an abundance of parameters and assessment methods. The aim of this article is to introduce the Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA), a new approach for a comprehensive characterization of CGM point accuracy which is based on the U.S. Food and Drug Administration requirements for "integrated" CGM systems.
The statistical concept of tolerance intervals and data from two approved CGM systems was used to illustrate the CG-DIVA.
The CG-DIVA characterizes the expected range of deviations of the CGM system from a comparison method in different glucose concentration ranges and the variability of accuracy within and between sensors. The results of the CG-DIVA are visualized in an intuitive and straightforward graphical presentation. Compared with conventional accuracy characterizations, the CG-DIVA infers the expected accuracy of a CGM system and highlights important differences between CGM systems. Furthermore, it provides information on the incidence of large errors which are of particular clinical relevance. A software implementation of the CG-DIVA is freely available (https://github.com/IfDTUlm/CGM_Performance_Assessment).
We argue that the CG-DIVA can simplify the discussion and comparison of CGM accuracy and could replace the high number of conventional approaches. Future adaptations of the approach could thus become a putative standard for the accuracy characterization of CGM systems and serve as the basis for the definition of future CGM performance requirements.
连续血糖监测(CGM)系统的准确性对于糖尿病患者血糖水平的管理至关重要。然而,大量的参数和评估方法使得 CGM 准确性的讨论变得具有挑战性。本文的目的是介绍连续血糖偏差间隔和可变性分析(CG-DIVA),这是一种新的综合评估 CGM 点准确性的方法,它基于美国食品和药物管理局对“集成”CGM 系统的要求。
使用统计学概念容忍区间和两个经过批准的 CGM 系统的数据来说明 CG-DIVA。
CG-DIVA 描述了 CGM 系统在不同葡萄糖浓度范围内与比较方法的偏差预期范围,以及传感器内和传感器之间的准确性可变性。CG-DIVA 的结果以直观和直接的图形表示。与传统的准确性特征描述相比,CG-DIVA 推断了 CGM 系统的预期准确性,并突出了 CGM 系统之间的重要差异。此外,它提供了有关大误差发生率的信息,这些信息具有特殊的临床意义。CG-DIVA 的软件实现可免费获得(https://github.com/IfDTUlm/CGM_Performance_Assessment)。
我们认为,CG-DIVA 可以简化 CGM 准确性的讨论和比较,并可能取代大量传统方法。该方法的未来改编可以成为 CGM 系统准确性特征描述的潜在标准,并为未来 CGM 性能要求的定义提供基础。